search
Back to results

Endothelial Injury Mechanism in Elderly Patients Undergoing Major Surgery

Primary Purpose

Endothelial Dysfunction, Blood Brain Barrier Defect, Postoperative Cognitive Dysfunction

Status
Completed
Phase
Phase 4
Locations
China
Study Type
Interventional
Intervention
Dexmedetomidine
Saline
Sponsored by
The First Affiliated Hospital of Anhui Medical University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Endothelial Dysfunction

Eligibility Criteria

65 Years - 90 Years (Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Written informed consent;
  2. Patients undergoing selective major gastrointestinal surgery with laparoscope and general anesthesia;
  3. Age 65-90 yrs;
  4. Anesthesia Society of American (ASA) Scale II~IV;
  5. Anticipated surgery time 2-6 hrs;

Exclusion Criteria:

  1. Dementia patients(Mini-mental state examination< 20)
  2. Factors existed that affect cognition assessment such as language,visual,and auditory dysfunction;
  3. Unstable metal status and mental disease;
  4. A hematocrit value less than 28%in perioperative period;
  5. Patients with abnormal preoperative inflammatory indicators(Higher white blood cell and C-reactive protein);
  6. Patients undergoing cardiac and neural surgery;
  7. Parkinson's Disease;
  8. Sure or suspected abuse of analgesic and sedation drug.

Sites / Locations

  • The First Affiliated Hospital of Anhui Medical University
  • Hangzhou cancer hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Dexmedetomidine

Controlled

Arm Description

0.5μg/kg Dexmedetomidine as initial loading dose is given for 15 minutes before induction of anesthesia, followed by a maintenance infusion of 0.4μg/kg/h and stopped 30 minutes before the surgery over.

0.5μg/kg Saline as initial loading dose is given for 15 minutes before induction of anesthesia, followed by a maintenance infusion of 0.4μg/kg/h and stopped 30 minutes before the surgery over.

Outcomes

Primary Outcome Measures

The change of incidence of postoperative delirium
Through CAM-ICU to assess the incidence of the postoperative delirium.
The change of incidence of postoperative cognition dysfunction
The neuropsychological tests performed at the day before the surgery, the 3rd and 7th day after the surgery respectively.Calculate the difference(ΔX) between the score obtained before surgery and 3 or 7 days after the surgery (there are both positive and negative, we use the absolute value), with this difference( ΔX) divided by the standard deviation(SD)of the difference of the normal population, that is ΔX / SD and it is the Z score.If a patient has two or more than two of the absolute value of Z scores ≥1.96, the postoperative cognition dysfunction(POCD) is exist.

Secondary Outcome Measures

endothelial injury levels
Plasma of patients was collected to test heparan sulphate and syndecan-1.
Blood-brain barrier permeability
Plasma of patients was collected to test S100B level
The serum concentrations of BDNF
Serum level of brain-derived neurotrophic factor (BDNF) was measured.
Inflammatory factor
Plasma of patients was collected to test cytokines IL-2, IL-6, TNF-α and VEGF level.

Full Information

First Posted
August 13, 2018
Last Updated
February 7, 2021
Sponsor
The First Affiliated Hospital of Anhui Medical University
Collaborators
Hangzhou Cancer Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT03639896
Brief Title
Endothelial Injury Mechanism in Elderly Patients Undergoing Major Surgery
Official Title
Endothelial Injury Mechanism of Cognitive Decline and Intervention Study in Elderly Patients Undergoing Major Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
September 2019
Overall Recruitment Status
Completed
Study Start Date
July 1, 2019 (Actual)
Primary Completion Date
October 30, 2020 (Actual)
Study Completion Date
October 31, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
The First Affiliated Hospital of Anhui Medical University
Collaborators
Hangzhou Cancer Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The incidence of postoperative cognitive injury is high in elderly patients, especially after major surgery. The relevant pathophysiological mechanisms are still unclear, and the possible mechanisms that have been proposed so far include inflammation, neurotransmitter imbalance and metabolic disorders. In recent years, clinical studies of acute brain dysfunction after vascular endothelial injury have attracted attention. Degradation of the endothelial glycocalyx layer and subsequent shedding of its constituents is seen as an early marker of endothelial injury, and may increase vascular permeability.Many preclinical and clinical studies have demonstrated an association between inflammatory cytokines such as TNF-α, IL-1β, IL-6, and IL-10 and glycocalyx degradation biomarkers. The scholars found evidence of plasma endothelial injury after abdominal open surgery in the elderly. Dexmedetomidine could attenuate stress response such as TNF-α, IL-1β and IL-6. Based on the above evidence, we hypothesize that elderly patients experience inflammatory response secondary to surgical traumatic stress after major surgery, greatly increasing the degree of endothelial injury (heparan sulphate and syndecan-1), reducing brain perfusion while increasing Blood-brain barrier permeability (S100B level), promoting the release of cytokines Interleukin-2(IL-2), Interleukin-6(IL-6), tumor necrosis factor-alpha(TNF-α) ,and vascular endothelial growth factor (VEGF) while reducing brain-derived neurotrophic factor(BDNF) synthesis, then leading to postoperative acute spasm. We would test the hypothesis that can reverse these effects and improve cognitive deficits.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Endothelial Dysfunction, Blood Brain Barrier Defect, Postoperative Cognitive Dysfunction

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
464 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Dexmedetomidine
Arm Type
Experimental
Arm Description
0.5μg/kg Dexmedetomidine as initial loading dose is given for 15 minutes before induction of anesthesia, followed by a maintenance infusion of 0.4μg/kg/h and stopped 30 minutes before the surgery over.
Arm Title
Controlled
Arm Type
Placebo Comparator
Arm Description
0.5μg/kg Saline as initial loading dose is given for 15 minutes before induction of anesthesia, followed by a maintenance infusion of 0.4μg/kg/h and stopped 30 minutes before the surgery over.
Intervention Type
Drug
Intervention Name(s)
Dexmedetomidine
Intervention Description
0.5μg/kg Dexmedetomidine as initial loading dose is given for 15 minutes before induction of anesthesia, followed by a maintenance infusion of 0.4μg/kg/h and stopped 30 minutes before the surgery over.
Intervention Type
Drug
Intervention Name(s)
Saline
Intervention Description
0.5μg/kg saline as initial loading dose is given for 15 minutes before induction of anesthesia, followed by a maintenance infusion of 0.4μg/kg/h and stopped 30 minutes before the surgery over.
Primary Outcome Measure Information:
Title
The change of incidence of postoperative delirium
Description
Through CAM-ICU to assess the incidence of the postoperative delirium.
Time Frame
The 1st, 2nd and 7th day after the surgery.
Title
The change of incidence of postoperative cognition dysfunction
Description
The neuropsychological tests performed at the day before the surgery, the 3rd and 7th day after the surgery respectively.Calculate the difference(ΔX) between the score obtained before surgery and 3 or 7 days after the surgery (there are both positive and negative, we use the absolute value), with this difference( ΔX) divided by the standard deviation(SD)of the difference of the normal population, that is ΔX / SD and it is the Z score.If a patient has two or more than two of the absolute value of Z scores ≥1.96, the postoperative cognition dysfunction(POCD) is exist.
Time Frame
1 day Before surgery,the 3rd,7th day after the surgery.
Secondary Outcome Measure Information:
Title
endothelial injury levels
Description
Plasma of patients was collected to test heparan sulphate and syndecan-1.
Time Frame
1 day Before surgery,the 1st, 2nd, 3rd,7th day after the surgery.
Title
Blood-brain barrier permeability
Description
Plasma of patients was collected to test S100B level
Time Frame
1 day Before surgery,the 1st, 2nd, 3rd,7th day after the surgery.
Title
The serum concentrations of BDNF
Description
Serum level of brain-derived neurotrophic factor (BDNF) was measured.
Time Frame
1 day Before surgery,the 1st, 2nd, 3rd,7th day after the surgery.
Title
Inflammatory factor
Description
Plasma of patients was collected to test cytokines IL-2, IL-6, TNF-α and VEGF level.
Time Frame
1 day Before surgery,the 1st, 2nd, 3rd,7th day after the surgery.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
65 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Written informed consent; Patients undergoing selective major gastrointestinal surgery with laparoscope and general anesthesia; Age 65-90 yrs; Anesthesia Society of American (ASA) Scale II~IV; Anticipated surgery time 2-6 hrs; Exclusion Criteria: Dementia patients(Mini-mental state examination< 20) Factors existed that affect cognition assessment such as language,visual,and auditory dysfunction; Unstable metal status and mental disease; A hematocrit value less than 28%in perioperative period; Patients with abnormal preoperative inflammatory indicators(Higher white blood cell and C-reactive protein); Patients undergoing cardiac and neural surgery; Parkinson's Disease; Sure or suspected abuse of analgesic and sedation drug.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Xinqi Cheng, PhD
Organizational Affiliation
The First Affiliated Hospital of Anhui Medical University
Official's Role
Principal Investigator
Facility Information:
Facility Name
The First Affiliated Hospital of Anhui Medical University
City
Hefei
State/Province
Anhui
Country
China
Facility Name
Hangzhou cancer hospital
City
Hangzhou
State/Province
Zhejiang
Country
China

12. IPD Sharing Statement

Learn more about this trial

Endothelial Injury Mechanism in Elderly Patients Undergoing Major Surgery

We'll reach out to this number within 24 hrs